Search
MS Ireland warmly welcomes people with MS and their families to a national day of MS information, research and social opportunities.
Research funded by MS Ireland sheds light on secondary progressive MS
MS Ireland is delighted to announce results of a research project part funded by the Society which has discovered a possible connection between the signally pathway in the brain and the grey matter lesions that characterise MS.
The findings come from a research team in the National Centre for Biomedical Engineering and Science, NUI Galway, led by neuroscientist Dr Una FitzGerald and carried out by Dr. Jill McMahon, in collaboration with Dr Stephen McQuaid from Queen’s University Belfast. The research project “Endoplasmic reticulum (ER) stress as a component of neurodegeneration in MS grey matter lesions”, is one of only two research projects in the world examining the role of ER stress in grey matter lesions in MS.
The Irish research shows that lesions formed in the grey matter of the brain might be associated with a signalling pathway called endoplasmic reticulum (ER) stress. Higher levels of ER stress were discovered in lesioned areas in the grey matter of the brain in those with secondary progressive MS. MS is characterised by lesions, or a loss of myelin, in the central nervous system. This myelin speeds up nerve impulse production, and this is what gets damaged in the case of MS.
Read the full press release here.
Read the research team’s final report.
Read the Irish Times article on the research.
MS Ireland would like to thank our Voluntary Branches and other supporters who have contributed to our research fund. Each year MS Ireland supports a number of research projects. Read more about our funded projects here. If you would like more information or wish to make a donation to our fund, please contact Taragh Donohoe on 01 678 1600 or email
1 Million Irish Homes to be Asked to Join “Just 2 Will Do”
European Medicines Agency’s Committee for Medicinal Products for Human Use issues positive opinion on marketing authorisation application for FAMPYRA.
Novartis receives European Commission approval for Gilenya®, the first oral multiple sclerosis treatment for use in the EU
A presentation from Professor Michael D. Dake, Department of Cardiothoriac Surgery, Stanford University School of Medicine, Falk Cardiovascular Reseach Centre
Part 1:
http://www.youtube.com/watch?v=adbVIR1h7h8
Part 2:
http://www.youtube.com/watch?v=_IuuJKuZiKg
Fingolimod, under the trade name Gilenya, the first oral drug therapy for the treatment of MS, is now available under the direction of a neurologist. Gilenya is licensed as a second line therapy, making it suitable for people that have failed on conventional first line therapies or those individuals with highly active MS.
Thank you so much to Kingsland NS in Roscommon, who couldn’t participate in the MS READaTHON this year but still wanted to support MS Ireland. They decided to hold a Halloween Party instead with all funds raised going to MS Ireland! Some fantastic costumes guys!
CONGRATULATIONS to our two lucky winners, Rachel Douglas and Sue Carroll. They both win a signed copy of "Sally Go Round the Stars” by Sarah Webb & Claire Ranson.
Now, if you want to be in with a chance of winning some MS READaTHON goodies, simply answer the question below and you could win some pretty great books.
A big CONGRATULATIONS to Aghabullogue National School. The answer to last week's question was 'The Dormouse'. Prizes are on the way guys!